Xeraya Capital leads Rapid’s $60m fundraising round

The US-based Bain Capital Life Sciences Fund also took part in the round.

Xeraya Capital, the venturing arm of Malaysia’s sovereign wealth fund Khazanah Nasional Berhad, has led a $60m fundraising round for healthtech firm Rapid Micro Biosystems, Deal Street Asia has reported.

The round was co-led by the Bain Capital Life Sciences Fund and also featured Asahi Kasei Medical, Longitude Capital, Quaker Partners, TVM Capital, and Richard K. Mellon and Sons.

See more from this Government Report: Malaysia


Supporting articles

Copyright Mawsonia Limited 2010. Please don't cut articles from www.globalgovernmentventuring.com or the PDF and redistribute by email or post to the web without written permission.